|
Market Closed -
Oslo Bors
10:45:00 2026-10-05 EDT
|
5-day change | 1st Jan Change | ||
| 11.24 NOK | 0.00% |
|
+4.46% | +865.64% |
| 09-23 | Circio to Cancel Subsequent NOK200 Million Share Offering | MT |
| 09-20 | Circio Holding ASA(OB:CRNA) added to S&P Global BMI Index | CI |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
Developing Highly Targeted Immunotherapy Treatments | - | 10M | 123K | - | - | |||||
Total Assets | 565M | 100M | 28.14M | 21.83M | 10.76M | |||||
Interest Expense | -2.01M | -4.99M | -3.56M | -20K | -169K | |||||
Income Tax Expense | -52K | -62.43M | - | - | - | |||||
CAPEX | - | -4.96M | -193K | -189K | - | |||||
EBT | -98.02M | -495M | -111M | 57.52M | -45.91M | |||||
D&A | 1.31M | 393M | 1.77M | -1.1M | 25K | |||||
Operating Income | -95.6M | -494M | -101M | -42.49M | -41.05M | |||||
Net Income | -97.97M | -433M | -111M | 57.52M | -45.91M |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
- Stock Market
- Stocks
- TRVX Stock
- Financials Circio Holding ASA
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
